Protective effect of cytokines in mice to Pseudomonas aeruginosa infection.
Nakano
M
M
Department of Microbiology, Jichi Medical School, Tochigi, Japan.
Onozuka
K
K
Sakamoto
K
K
Nakano
Y
Y
Shinomiya
H
H
Saito-Taki
T
T
D000818:Animals; D003520:Cyclophosphamide / Q000494:pharmacology; D016207:Cytokines / Q000627:therapeutic use*; D005122:Exudates and Transudates / Q000166:cytology; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007375:Interleukin-1 / Q000627:therapeutic use; D007700:Kinetics; D007958:Leukocyte Count; D008233:Lymphotoxin-alpha / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D011552:Pseudomonas Infections / Q000382:microbiology / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D016207:Cytokines; D007166:Immunosuppressive Agents; D007375:Interleukin-1; D008233:Lymphotoxin-alpha; D014409:Tumor Necrosis Factor-alpha; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003520:Cyclophosphamide